We speculate that eosinophils in patients with T1D are upregulating CD16 in order to regulate activated T cells, but since the eosinophils do not express the suppressive protein galectin-10 and the adhesion molecule CD24 to the same extent as healthy subjects the suppression of and interaction with T cells is much weaker. The gene discussed is CLC; the disease is type 1 diabetes mellitus.